The medical technology company Monivent reports, as planned, small changes in both revenue and earnings in the first quarter. Revenue fell to SEK 0.3 million (0.7). Operating profit was SEK -2.5 million (-2.2). Net profit was SEK -2.6 million (-2.3).CEO Maria Lindqvist says that the company continues to focus on regulatory approvals in Europe and the USA as well as on securing long-term financing. After the quarter, a balance sheet for liquidation purposes has been prepared."The board and management are in discussions with potential investors together with financial advisers regarding financing and conversion of bridge loans. This is in order to restore the share capital and strengthen the company's liquidity for continued financing of the business. The board is positive about how the process is progressing," she says and continues."At present, the transition is also underway to hand over distribution to larger partners with a global presence and directly complementary product portfolios. By fully implementing this commercial strategy, the opportunities also look good for creating long-term profitability in the company."Monivent, SEK millionQ1-2026Q1-2025ChangeNet sales0.30.7-57.1%Operating profit-2.5-2.2Net profit-2.6-2.3